AZGP1 antibody (AA 61-210) (HRP)

Catalog No. ABIN7176721

Product Details anti-AZGP1 Antibody (HRP)

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Binding Specificity: AA 61-210

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AZGP1 antibody is conjugated to HRP

Application: ELISA

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Zinc-alpha-2-glycoprotein protein (61-210AA)

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for AZGP1

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Alternative Name: AZGP1 (AZGP1 Products)

Synonyms: Zag antibody, ZA2G antibody, ZAG antibody, ZA2GA antibody, Zna2gp antibody, alpha-2-glycoprotein 1, zinc antibody, alpha-2-glycoprotein 1, zinc-binding antibody, Azgp1 antibody, AZGP1 antibody

Background:

Background: Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids.

Aliases: Alpha 2 glycoprotein 1 zinc antibody, Alpha 2 glycoprotein 1 zinc binding antibody, Alpha 2 glycoprotein zinc antibody, Azgp1 antibody, ZA2G antibody, ZA2G_HUMAN antibody, ZAG antibody, Zinc alpha 2 glycoprotein precursor antibody, Zinc-alpha-2-glycoprotein antibody, Zn alpha 2 glycoprotein antibody, Zn alpha 2 GP antibody, Zn alpha2 glycoprotein antibody, Zn-alpha-2-glycoprotein antibody, Zn-alpha-2-GP antibody, ZNGP1 antibody

UniProt: P25311

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process